Spelling suggestions: "subject:"eric acid"" "subject:"eric cid""
91 |
Výzkum sklivce a vitreoretinálního rozhraní u mikrovaskulárních chorob sítnice se zaměřením na oční komplikace diabetes mellitus. / Research of vitreous and vitreoretinal interface in microvascular retinal disorders focussed on eye complications of diabetes mellitusKřížová, Libuše January 2016 (has links)
In this work I present conclusions of clinical-laboratory research focused on the patients with diabetic macular edema (DME). We performed biochemical and immunochemical analyses of vitreous samples that were collected during the pars plana vitrectomy. Moreover, at patients with non-proliferative diabetic retinopathy (NPDR) we assessed morphological characteristics of DME using optical coherence tomography (OCT). According to our findings, the vitreous and serum concentrations of uric acid and glucose were significantly higher in patients with diabetic retinopathy and DME compared to controls. Also total ratio (serum/ vitreous concentration) of uric acid and glucose was in diabetics significantly higher than in controls. The most important determinant of increasing concentration of both uric acid and glucose in the vitreous was the grade of diabetic retinopathy. Moreover, we demonstrated significant correlation between vitreous concentration of uric acid and concentration of the vascular endothelial growth factor (VEGF) in patients with DME and NPDR. We found further, that the volume of the macula (cube volume - CV) computed with the software of Cirrus HD-OCT correlates in diabetics significantly with the vitreous VEGF concentration, but not with uric acid. This OCT parameter could be used to...
|
92 |
Inflammation d’origine non-pathogénique durant la gestation, implication dans les complications de la grossesse et impact sur le développement cérébralBrien, Marie-Ève 03 1900 (has links)
INTRODUCTION : Le retard de croissance intra-utérin (RCIU), la prééclampsie (PE) et l’accouchement prématuré (AP) sont d’importantes pathologies de la grossesse fortement associées à un mauvais fonctionnement du placenta, organe central au développement du fœtus. Environ 5-12% de toutes les grossesses sont pathologiques et ces dernières sont associées avec un risque accru de désordres neurodéveloppementaux chez l’enfant. L'inflammation est un point central à toutes les complications de la grossesse et le lien causal entre l’inflammation et ces pathologies a été démontré à l’aide de plusieurs modèles animaux d’inflammation prénatale, menant à des dommages cérébraux chez les nouveau-nés. Cependant, la majorité des modèles utilisent des stimuli infectieux, bien que des pathogènes soient rarement détectés en clinique. Malgré l'absence d'infection détectable, des évidences d'inflammation, telles que des niveaux élevés de cytokines pro-inflammatoires et d’alarmines, sont présentes. Les alarmines sont des médiateurs endogènes et une autre cause d'inflammation de plus en plus associée aux pathologies de la grossesse. L’acide urique est une des alarmines les plus étudiées comme médiateur endogène d’inflammation, mais son effet sur la grossesse est peu connu. Ainsi, mon hypothèse était que l’exposition prénatale particulièrement à l’acide urique serait associée aux complications de la grossesse, serait une cause de dommage placentaire et subséquemment altèrerait le neurodéveloppement fœtal, menant à des dommages cérébraux à long terme chez l’enfant.
Mon OBJECTIF général était de comprendre le lien entre inflammation prénatale non-pathogénique, les complications de la grossesse et les effets sur le placenta et le cerveau en développement. Spécifiquement, j’ai déterminé la présence d’inflammation dans les complications majeures de la grossesse puis je me suis concentré sur la PE et l’implication de l’activation immunitaire dans cette pathologie. En parallèle, j’ai établi le lien entre l’inflammation non-pathogénique, les dommages placentaires et le RCIU. Finalement, j’ai évalué le neurodéveloppement après l’exposition in-utero à une inflammation non-pathogénique et j’ai investigué le potentiel d’un nouveau traitement dans mon modèle préclinique.
MÉTHODOLOGIES ET RÉSULTATS: J’ai analysé le profil inflammatoire de 200 femmes avec ou sans complications de la grossesse (Ctrl, PE, AP, RCIU) et j’ai démontré que chaque complication présente un profil inflammatoire circulant distinct, particulièrement présent chez les femmes avec PE. De plus, j’ai analysé plus en profondeur les femmes avec PE et observé une augmentation d’acide urique dans la circulation maternelle, en lien avec un profil immunitaire qui était altéré et des changements structuraux au niveau du placenta. Pour déterminer les effets directs de l'acide urique, nous avons utilisé des cultures de trophoblastes primaires, cellule principale du placenta, et des explants placentaires humains. Nous avons démontré que l’acide urique induisait un profil pro-inflammatoire augmentant particulièrement la sécrétion d’IL-1β et d’IL-6 et induisait aussi l'apoptose des trophoblastes. En parallèle, j’ai développé un nouveau modèle préclinique de rates gestantes qui ont été injectées par voie intrapéritonéale avec l’acide urique du temps de gestation 18 (G18) à G21. L’injection d'acide urique in vivo à la fin de la gestation chez le rat a entrainé l’augmentation de cytokines (IL-1β, TNF-α et IL-6) et l’infiltration de cellules immunitaires dans le placenta ainsi qu’un RCIU chez le fœtus qui persistait dans la période postnatale. De plus, les bébés exposés in-utero à l’acide urique avaient une altération neurodéveloppementale caractérisée par l’activation microgliale et astrogliale en plus d’une diminution des capacités motrices. Ces effets de l’acide urique étaient dépendants de l'IL-1β et bloqués par l’antagoniste spécifique du récepteur de l’IL-1 (IL-1Ra).
CONCLUSIONS: L’inflammation est associée à toutes les complications de la grossesse, mais les profils diffèrent selon la pathologie étudiée. La PE est associée à des changements immunitaires importants. L'acide urique à l'interface materno-fœtale induit inflammation et altère les fonctions placentaires de façon IL-1-dépendante. Finalement, l’exposition à l’acide urique en fin de gestation chez le rat induit l’inflammation placentaire, le RCIU et altère le développement cérébral des bébés. Un traitement prénatal anti-inflammatoire permet de minimiser l’inflammation et ses effets négatifs sur le cerveau. / INTRODUCTION: Intra-uterine growth restriction (IUGR), preeclampsia (PE) and preterm birth (PTB) are important pathologies of pregnancy strongly associated with poor placental function, a central organ for fetal development. About 5-12% of all pregnancies are pathological and this increases the risk of neurodevelopmental disorders. Inflammation is central to all pregnancy complications and the causal link has been demonstrated with several animal models of prenatal inflammation leading to brain damage in newborns. However, these models use infectious stimuli although pathogens are rarely detected clinically. Despite the absence of detectable infection, evidence of inflammation, such as elevated levels of pro-inflammatory cytokines and alarmins, is observed. Alarmins are endogenous mediators, another cause of inflammation increasingly associated with pathological pregnancies. Uric acid is one of the most studied alarmins, however its effect on pregnancy is mostly unknown. Thus, my hypothesis was that prenatal exposure particularly to uric acid is associated with pregnancy complications and is a cause of placental damage which subsequently impairs fetal neurodevelopment, leading to long-term brain damage in the child.
My general OBJECTIVE was to understand the link between non-pathogenic prenatal inflammation, pregnancy complications and its effect on the placenta and the developing brain. Specifically, I detected the presence of inflammation in major pregnancy complications and subsequently focused on PE and its immune activation. In parallel, I established the causal link between non-infectious inflammation, placental damage and IUGR. Finally, I evaluated brain development following in utero inflammation and investigated a therapeutic target in my preclinical model.
METHODS AND RESULTS: I analyzed the inflammatory profile of 200 women with or without pregnancy complications (Ctrl, IUGR, PE, PTB) and demonstrated that each complication has a distinct circulating inflammatory profile, particularly in women with PE. In addition, I further analyzed women with PE and observed a uric acid increase in the maternal circulation, related to an altered immune profile and structural changes in the placenta. To determine the direct effects of uric acid, we used cultures of primary trophoblasts, the main cell of the placenta, and human placental explants. We have shown that uric acid induces a pro-inflammatory profile, particularly increasing the secretion of IL-1β and IL-6 and induces apoptosis of trophoblasts. In parallel, I developed a new preclinical model of pregnant rats that were injected intraperitoneally with uric acid from gestation time 18 (G18) to G21. The injection of uric acid at the end of gestation in the rat caused increase cytokines (IL-1β, TNF-α and IL-6), the infiltration of immune cells in the placenta as well as an IUGR in the fetus that persisted into the postnatal period. Additionally, babies exposed to uric acid in utero have neurodevelopmental impairment characterized by microglial and astroglial activation in addition to decreased motor function. These effects of uric acid was dependent on IL-1β and was blocked by the IL-1 receptor antagonist (IL-1Ra).
CONCLUSIONS: Inflammation is associated with all pregnancy complications, however, with different profiles depending on the pathology studied. PE is associated with significant immune changes. Uric acid at the maternal-fetal interface induced inflammation and altered placental functions in an IL-1-dependent manner. Ultimately, exposure to uric acid in late rat pregnancy induced placental inflammation, IUGR, and impaired brain development. Prenatal anti-inflammatory treatment helped minimize inflammation and these negative effects on the brain.
|
93 |
Stanovení vybraných komponent v lidské moči elektroforézou v krátké kapiláře. / Determination of selected components in human urine with electrophoresis in short capillary.Makrlíková, Anna January 2015 (has links)
Capillary zone electrophoresis is frequently used in various analyses. In this diploma thesis a hydrodynamic sample introduction method controlled by pressure pulse has been proposed for short-capillary electrophoresis. The base electrolyte flushes sample from the loop of a six-way sampling valve and is carried to the injection end of the capillary. At the time when the sample zone reached the capillary, a short pressure impulse is generated in the electrolyte stream, which provides injection of the sample into the capillary. Then the electrolyte flow is stopped and the separation voltage is turned on. The amount of sample introduced to the capillary is controlled by the duration of the pressure pulse. This new sample introduction method was tested in the determination of ammonia, histidine, creatinine, uric acid and hippuric acid in human urine and for rapid screening of the contents of the inorganic ions in cerebrospinal fluid and blood plasma. The determination was performed in a capillary with an overall length of 10,5 cm and two base electrolytes was tested - 50 mM MES + 5 mM NaOH (pH 5,10) and 1 M acetic acid + 1,5 mM crown ether 18-crown-6 (pH 2,40). Using dual detection techniques contactless conductivity and UV spectrometric detection, anorganic and organic substances in the sample could...
|
94 |
Investigation of the cross-talk between gut microbes and plasma metabolites in the development of post-traumatic epilepsyMäkinen, Nelly January 2024 (has links)
The aim of this project has been to investigate whether there are correlations to be found between gut microbes and serum metabolites, which could be involved in the development of epilepsy. To do so, metabolomics data containing metabolites and metagenomics data containing bacteria have been integrated and used in a pipeline utilizing the software package DIABLO in R Studio. DIABLO stands for Data Integration Analysis for Biomarker discovery using Latent cOmponents and utilizes multi-block pls-da to integrate multiple omics data sets to find potential biomarkers. The results in this project are mainly divided into two groups, the first group being from taking samples at an early time point, where subjects have not yet developed symptoms of epilepsy and the second group being from taking samples at a late time point, where the subjects have developed epilepsy. To find biomarkers in the data used for the integration, two subgroups are of highest interest, namely subgroup PTE, which is the group that develops epilepsy symptoms after an induced trauma to the brain, as well as subgroup TBI which do not develop epilepsy symptoms after an induced trauma to the brain. Results from the early time point suggests that bacteria such as those from Phelethenecus, Christenselellales, Ventrimonas, Ruminococcaceae and Acetatifactor, as well as metabolites such as LPC 17:0, Indole and Indole-3-carboxyaldehyde might be of interest in finding biomarkers previous to the development of epilepsy after induced brain trauma. Results from the late time point suggests that bacteria such as those from Muribaculaceae and Avidehalobacter, as well as metabolites such as Dioctyl sulfosuccinate, Canrenone, LPC 18:0, Uric acid, Arjunolic acid and Pseudouridine might be of interest in finding underlying mechanisms behind the existing condition of epilepsy. The hope is that findings in this paper might aid in future development of knowledge behind this disease as well as its underlying mechanisms.
|
Page generated in 0.0602 seconds